/
EW
$91.91-$0.65 (-0.70%)live
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
2
institutions
Market cap
$53.6B
576M shares
52-week range
$72.30 – $96.29
82% from low
Sector
ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES
Exchange
NYSE
CS
Change$-22.45
Edwards Lifesciences Corp
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.
www.edwards.com- Employees
- 16,000
- IPO / List date
- Apr 3, 2000
- HQ
- IRVINE, CA
Held by traders on TradeandTell
No one on the platform currently holds EW.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Bridgewater Associatesas of 2026-03-31 | 171,923 | $13.8M |
| Renaissance Technologiesas of 2026-03-31 | 29,000 | $2.3M |
Insider activity (SEC Form 4)
Stock splits
| Execution date | Ratio |
|---|---|
| 2020-06-01 | 3-for-1 |
| 2015-12-14 | 2-for-1 |
| 2010-05-28 | 2-for-1 |
Recent trades on TradeandTell
No one on the platform has traded EW yet.
